Secret Drug Price Rebates Will Go Away, Pfizer CEO Predicts
Photographer: Daniel Acker/Bloomberg
This article is for subscribers only.
Drugmakers will likely get rid of secret discounts to middlemen that have become a focus of the U.S. drug-cost debate, Pfizer Inc. Chief Executive Officer Ian Read predicted Tuesday.
“We’re going to go to a marketplace where we don’t have rebates,” Read told analysts while discussing the company’s second-quarter financial results.